Inert fluorinated gas MRI: a new pulmonary imaging modality

NMR in Biomedicine

Volumn 27, Issue 12, 2014, Pages 1525-1534

  Couch, Marcus J ^a,b   Ball, Iain K ^b   Li, Tao ^b   Fox, Matthew S ^a,b   Ouriadov, Alexei V ^b   Biman, Birubi ^c,d,e   Albert, Mitchell S ^a,b  

^a LAKEHEAD UNIVERSITY   (Canada)

^b Thunder Bay Regional Research Institute   (Canada)

^c THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE   (Canada)

^d NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Apparent diffusion coefficient; Functional lung imaging; Hyperpolarized gas MRI; Inert fluorinated gas MRI; UTE; Ventilation gradients

Indexed keywords

BIOLOGICAL ORGANS; DIAGNOSIS; IMAGE ENHANCEMENT; INERT GASES; MEDICAL IMAGING; PETROLEUM PROSPECTING; SURFACE DIFFUSION;

APPARENT DIFFUSION COEFFICIENT; GYROMAGNETIC RATIO; HEALTHY VOLUNTEERS; HIGH QUALITY IMAGES; HYPERPOLARIZED; LONGITUDINAL RELAXATION; LUNG IMAGING; ON-GOING IMPROVEMENT;

MAGNETIC RESONANCE IMAGING;

BIOLOGICAL MARKER; FLUORINE; INERT GAS; ISOTOPE;

AIR CONDITIONING; BREATHING FREQUENCY MONITOR; DIAGNOSTIC IMAGING; FUNCTIONAL LUNG IMAGING; HUMAN; IMAGE QUALITY; LONGITUDINAL STUDY; LUNG DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; REVIEW; THORAX RADIOGRAPHY; ANIMAL; BREATHING; DIAGNOSTIC USE; GRAVITY; HALOGENATION; LUNG; PHYSIOLOGY; PROCEDURES;

ANIMALS; GRAVITATION; HALOGENATION; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; NOBLE GASES; RESPIRATION;

EID: 84911807995     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3165     Document Type: Review

References (69)

1. Boulet LP, Bourbeau J, Skomro R, Gupta S. Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation. Can. Respir. J. 2013; 20: 265-269.
2. Martinez FD, Vercelli D. Asthma. Lancet 2013; 382: 1360-1372.
3. Vijayan VK. Chronic obstructive pulmonary disease. Indian J. Med. Res. 2013; 137: 251-269.
4. Mills GH, Wild JM, Eberle B, Van Beek EJ. Functional magnetic resonance imaging of the lung. Br. J. Anaesth. 2003; 91: 16-30.
5. Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized 3D ultrashort echo time pulmonary MRI. Magn. Reson. Med. 2013; 70: 1241-1250.
6. Sa RC, Cronin MV, Henderson AC, Holverda S, Theilmann RJ, Arai TJ, Dubowitz DJ, Hopkins SR, Buxton RB, Prisk GK. Vertical distribution of specific ventilation in normal supine humans measured by oxygen-enhanced proton MRI. J. Appl. Physiol. 2010; 109: 1950-1959.
7. Henderson AC, Sa RC, Theilmann RJ, Buxton RB, Prisk GK, Hopkins SR. The gravitational distribution of ventilation-perfusion ratio is more uniform in prone than supine posture in the normal human lung. J. Appl. Physiol. 2013; 115: 313-324.
8. Bauman G, Puderbach M, Deimling M, Jellus V, Chefd'hotel C, Dinkel J, Hintze C, Kauczor HU, Schad LR. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of Fourier decomposition in proton MRI. Magn. Reson. Med. 2009; 62: 656-664.
9. Altes TA, Salerno M. Hyperpolarized gas MR imaging of the lung. J. Thorac. Imaging 2004; 19: 250-258.
10. 19F MR imaging with inhaled fluorinated gas mixtures in healthy volunteers: feasibility. Radiology 2013; 269: 903-909.
11. Halaweish AF, Moon RE, Foster WM, Soher BJ, McAdams HP, MacFall JR, Ainslie MD, MacIntyre NR, Charles HC. Perfluoropropane gas as a magnetic resonance lung imaging contrast agent in humans. Chest 2013; 144: 1300-1310.
12. 129Xe. Nature 1994; 370: 199-201.
13. Albert MS, Balamore D. Development of hyperpolarized noble gas MRI. Nucl. Instrum. Methods Phys. Res. A 1998; 402: 441-453.
14. Mazzanti ML, Walvick RP, Zhou X, Sun Y, Shah N, Mansour J, Gereige J, Albert MS. Distribution of hyperpolarized xenon in the brain following sensory stimulation: preliminary MRI findings. PLoS One 2011; 6: e21607.
15. 129Xe. NMR Biomed. 2010; 24: 170-175.
16. 3He. J. Magn. Reson. 2013; 229: 173-186.
17. Peterson ET, Dai J, Holmes JH, Fain SB. Measurement of lung airways in three dimensions using hyperpolarized helium-3 MRI. Phys. Med. Biol. 2011; 56: 3107-3122.
18. Parraga G, Ouriadov A, Evans A, McKay S, Lam WW, Fenster A, Etemad-Rezai R, McCormack D, Santyr G. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest. Radiol. 2007; 42: 384-391.
19. 3He MRI. J. Magn. Reson. 1999; 141: 207-216.
20. Moller HE, Chen XJ, Saam B, Hagspiel KD, Johnson GA, Altes TA, de Lange EE, Kauczor HU. MRI of the lungs using hyperpolarized noble gases. Magn. Reson. Med. 2002; 47: 1029-1051.
21. Kouzes RT, Ely JH, Erikson LE, Kernan WJ, Lintereur AT, Siciliano ER, Stephens DL, Stromswold DC, Van Ginhoven RM, Woodring ML. Neutron detection alternatives to He-3 for national security applications. Nucl. Instrum. Methods A 2010; 623: 1035-1045.
22. 129Xe for human lung imaging studies. Acad. Radiol. 2008; 15: 683-692.
23. 129Xe hyperpolarizer for NMR and MRI. Proc. Natl. Acad. Sci. U. S. A. 2013; 110: 14150-14155.
24. 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012; 265: 600-610.
25. 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. Magn. Reson. Med. 2011; 65: 1154-1165.
26. 129Xe apparent diffusion coefficient anisotropy in chronic obstructive pulmonary disease. Magn. Reson. Med. 2013; 70: 1699-1706.
27. Qing K, Ruppert K, Jiang Y, Mata JF, Miller GW, Shim YM, Wang C, Ruset IC, Hersman FW, Altes TA, Mugler JP 3rd. Regional mapping of gas uptake by blood and tissue in the human lung using hyperpolarized xenon-129 MRI. J. Magn. Reson. Imaging 2014; 39: 346-359.
28. 129Xe MR imaging in healthy volunteers and patients. Radiology 2012; 262: 279-289.
29. Wagner PD. The multiple inert gas elimination technique (MIGET). Intensive Care Med. 2008; 34: 994-1001.
30. 19F-MRI at low spin density. Phys. Chem. Chem. Phys. 2010; 12: 10309-10312.
31. Chang YV, Conradi MS. Relaxation and diffusion of perfluorocarbon gas mixtures with oxygen for lung MRI. J. Magn. Reson. 2006; 181: 191-198.
32. Sarkar K, Katiyar A, Jain P. Growth and dissolution of an encapsulated contrast microbubble: effects of encapsulation permeability. Ultrasound Med. Biol. 2009; 35: 1385-1396.
33. 6 composition on apparent diffusion coefficients. Respir. Physiol. Neurobiol. 2005; 148: 43-56.
34. Leawoods JC, Yablonskiy DA, Saam B, Gierada DS, Conradi MS. Hyperpolarized He-3 gas production and MR imaging of the lung. Concepts Magn. Reson. 2001; 13: 277-293.
35. Kuethe DO, Caprihan A, Gach HM, Lowe IJ, Fukushima E. Imaging obstructed ventilation with NMR using inert fluorinated gases. J. Appl. Physiol. 2000; 88: 2279-2286.
36. 129Xe MRI of the human lung. J. Magn. Reson. Imaging 2013; 37: 313-331.
37. 3He washout with 2D and 3D MRI. J. Appl. Physiol. 2014; 116: 129-139.
38. Hamedani H, Kadlececk S, Han B, Emami K, Xin Y, Ishii M, Rossman M, Rizi R. A simultaneous multi-breath scheme for measurement of ADC, pAO2 and fractional ventilation using 3He MRI in human. In: Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, UT, 2013; 1468.
39. Heidelberger E, Lauterbur PC. Gas phase 19F-NMR zeugmatography: a new approach to lung ventilation imaging. In: Proceedings of the 1st Annual Meeting ISMRM, Boston, MA, 1982; 70-71.
40. Rinck PA, Petersen SB, Lauterbur PC. NMR-Imaging von fluorhaltigen Substanzen. 19Fluor-Ventilations- und -Perfusionsdarstellungen. Fortschr. Röntgenstr. 1984; 140: 239-243.
41. Rinck PA, Peterson SB, Heidelberger E, Acuff V, Reinders J, Bernardo ML, Hedges LK, Lauterbur PC. NMR Ventilation imaging of the lungs using perfluorinated gases. Magn. Reson. Med. 1984; 1: 237.
42. Kuethe DO, Caprihan A, Fukushima E, Waggoner RA. Imaging lungs using inert fluorinated gases. Magn. Reson. Med. 1998; 39: 85-88.
43. Lauterbur PC. Image formation by induced local interactions - examples employing nuclear magnetic resonance. Nature 1973; 242: 190-191.
44. Santyr GE, Lam WW, Parra-Robles JM, Taves TM, Ouriadov AV. Hyperpolarized noble gas magnetic resonance imaging of the animal lung: approaches and applications. J. Appl. Phys. 2009; 105: 102004.
45. Wolf U, Scholz A, Terekhov M, Muennemann K, Kreitner K, Werner C, Dueber C, Schreiber WG. Fluorine-19 MRI of the lung: first human experiment. In: Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada, 2008; 3207.
46. Halaweish AF, Charles HC. Physiorack: an integrated MRI safe/conditional, gas delivery, respiratory gating, and subject monitoring solution for structural and functional assessments of pulmonary function. J. Magn. Reson. Imaging 2014; 39: 735-741.
47. 3He magnetic resonance functional imaging semiautomated segmentation. Acad. Radiol. 2012; 19: 141-152.
48. Miller GW, Altes TA, Brookeman JR, De Lange EE, Mugler JP 3rd. Hyperpolarized 3He lung ventilation imaging with B1-inhomogeneity correction in a single breath-hold scan. Magn. Reson. Mater. Phys. Biol. Med. 2004; 16: 218-226.
49. 6. Magn. Reson. Med. 2002; 48: 547-549.
50. 6) gas. Magn. Reson. Med. 2001; 45: 605-613.
51. Wolf U, Scholz A, Heussel CP, Markstaller K, Schreiber WG. Subsecond fluorine-19 MRI of the lung. Magn. Reson. Med. 2006; 55: 948-951.
52. Wolf U, Scholz A, Terekhov M, Koebrich R, David M, Schreiber LM. Visualization of inert gas wash-out during high-frequency oscillatory ventilation using fluorine-19 MRI. Magn. Reson. Med. 2010; 64: 1478-1483.
53. Chon D, Simon BA, Beck KC, Shikata H, Saba OI, Won C, Hoffman EA. Differences in regional wash-in and wash-out time constants for xenon-CT ventilation studies. Respir. Physiol. Neurobiol. 2005; 148: 65-83.
54. 6 with respiratory gas analysis. Magn. Reson. Imaging 2009; 27: 549-556.
55. 19fluorine-enhanced MRI: initial experiences and future developments. In: Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, UT, 2013; 4111.
56. 3He MRI. Magn. Reson. Med. 2002; 48: 223-232.
57. 3He MRI with Xe-enhanced computed tomography imaging for ventilation mapping of rat lung. NMR Biomed. 2011; 24: 1073-1080.
58. 129Xe magnetic resonance imaging. Magn. Reson. Med. 2012; 68: 1623-1631.
59. Emami K, Hamedani H, Kadlececk S, Han B, Xin Y, Ishii M, Rossman M, Rizi R. A pilot fractional ventilation imaging study in healthy subjects, asymptomatic smokers and obstructive pulmonary disease patients. In: Proceedings of the 21st Annual Meeting ISMRM, Salt Lake City, UT, 2013; 1463.
60. 6. Magn. Reson. Med. 2005; 54: 460-463.
61. Carrero-Gonzalez L, Kaulisch T, Stiller D. In vivo diffusion-weighted MRI using perfluorinated gases: ADC comparison between healthy and elastase-treated rat lungs. Magn. Reson. Med. 2013; 70: 1761-1764.
62. 3He and perfluorocarbon gas diffusion MRI of lungs. Prog. Nucl. Magn. Reson. Spectrosc. 2006; 48: 63-83.
63. 19F MR imaging of ventilation and diffusion in excised lungs. Magn. Reson. Med. 2005; 54: 577-585.
64. Yablonskiy DA, Sukstanskii AL, Quirk JD, Woods JC, Conradi MS. Probing lung microstructure with hyperpolarized noble gas diffusion MRI: theoretical models and experimental results. Magn. Reson. Med. 2013; 71: 486-505.
65. West JB. Pulmonary Pathophysiology. Lippincott Williams and Wilkins: Philadelphia, PA, 2013.
66. 3He MRI. Magn. Reson. Med. 2004; 52: 65-72.
67. 1 of inert fluorinated gases. Magn. Reson. Med. 2008; 59: 739-746.
68. Lam WW, Holdsworth DW, Du LY, Drangova M, McCormack DG, Santyr GE. Micro-CT imaging of rat lung ventilation using continuous image acquisition during xenon gas contrast enhancement. J. Appl. Physiol. 2007; 103: 1848-1856.
69. 3He MRI-based assessment of posture-dependent regional ventilation gradients in rats. J. Appl. Physiol. 2005; 98: 2259-2267.